Cargando…

Chemical Mechanism of UDP-Galactopyranose Mutase from Trypanosoma cruzi: A Potential Drug Target against Chagas' Disease

UDP-galactopyranose mutase (UGM) is a flavoenzyme that catalyzes the conversion of UDP-galactopyranose to UDP-galactofuranose, the precursor of galactofuranose (Galf). Galf is found in several pathogenic organisms, including the parasite Trypanosoma cruzi, the causative agent of Chagas' disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oppenheimer, Michelle, Valenciano, Ana Lisa, Kizjakina, Karina, Qi, Jun, Sobrado, Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308961/ https://www.ncbi.nlm.nih.gov/pubmed/22448231 http://dx.doi.org/10.1371/journal.pone.0032918

Ejemplares similares

Targeting UDP-Galactopyranose Mutases from Eukaryotic Human Pathogens
por: Kizjakina, Karina, et al.
Publicado: (2013)

Fluorescence Polarization Binding Assay for Aspergillus fumigatus Virulence Factor UDP-Galactopyranose Mutase
por: Qi, Jun, et al.
Publicado: (2011)

Contributions of Unique Active Site Residues of Eukaryotic UDP-Galactopyranose Mutases to Substrate Recognition and Active Site Dynamics
por: Da Fonseca, Isabel, et al.
Publicado: (2014)

QM/MM Molecular Dynamics Study of the Galactopyranose → Galactofuranose Reaction Catalysed by Trypanosoma cruzi UDP-Galactopyranose Mutase
por: Pierdominici-Sottile, Gustavo, et al.
Publicado: (2014)

Identification of Aspergillus fumigatus UDP-Galactopyranose Mutase Inhibitors
por: Martin del Campo, Julia S., et al.
Publicado: (2017)

In Crystallo Capture of a Covalent Intermediate in the UDP-Galactopyranose Mutase Reaction
por: Mehra-Chaudhary, Ritcha, et al.
Publicado: (2016)

Author Correction: Identification of Aspergillus fumigatus UDP-Galactopyranose Mutase Inhibitors
por: Martin del Campo, Julia S., et al.
Publicado: (2018)

Purification, crystallization and preliminary X-ray diffraction data of UDP-galactopyranose mutase from Aspergillus fumigatus
por: Penman, George A., et al.
Publicado: (2012)

Cynaroside inhibits Leishmania donovani UDP-galactopyranose mutase and induces reactive oxygen species to exert antileishmanial response
por: Tabrez, Shams, et al.
Publicado: (2021)

UDP-4-Keto-6-Deoxyglucose, a Transient Antifungal Metabolite, Weakens the Fungal Cell Wall Partly by Inhibition of UDP-Galactopyranose Mutase
por: Ma, Liang, et al.
Publicado: (2017)

Structural Insight into the Unique Substrate Binding Mechanism and Flavin Redox State of UDP-galactopyranose Mutase from Aspergillus fumigatus
por: van Straaten, Karin E., et al.
Publicado: (2012)

Aspergillus nidulans Cell Wall Composition and Function Change in Response to Hosting Several Aspergillus fumigatus UDP-Galactopyranose Mutase Activity Mutants
por: Alam, Md Kausar, et al.
Publicado: (2014)

Biosynthesis of Galactofuranose in Kinetoplastids: Novel Therapeutic Targets for Treating Leishmaniasis and Chagas' Disease
por: Oppenheimer, Michelle, et al.
Publicado: (2011)

RNA interference mediated knockdown of Brugia malayi UDP-Galactopyranose mutase severely affects parasite viability, embryogenesis and in vivo development of infective larvae
por: Misra, Sweta, et al.
Publicado: (2017)

Pyrazole and Triazole Derivatives as Mycobacterium tuberculosis UDP-Galactopyranose Inhibitors
por: Ahmed, Dalia M., et al.
Publicado: (2022)

Molecular characteristics of plant UDP-arabinopyranose mutases
por: Saqib, Anam, et al.
Publicado: (2019)

Meiotic sex in Chagas disease parasite Trypanosoma cruzi
por: Schwabl, Philipp, et al.
Publicado: (2019)

Peeking into the mysterious world of Trypanosoma cruzi and Chagas disease
por: Macedo, Andréa M, et al.
Publicado: (2022)

Trypanosoma cruzi and Chagas disease: diversity, progress and challenges
por: Miles, Michael A
Publicado: (2022)

Identification of a Golgi-localized UDP-N-acetylglucosamine transporter in Trypanosoma cruzi
por: Baptista, Carlos Gustavo, et al.
Publicado: (2015)

Trypanosoma cruzi trans-Sialidase as a Potential Vaccine Target Against Chagas Disease
por: da Costa, Kelli Monteiro, et al.
Publicado: (2021)

Trypanosoma cruzi Induces Regulatory B Cell Alterations in Patients With Chronic Chagas Disease
por: Girard, Magalí C., et al.
Publicado: (2021)

Nationwide Exposure of U.S. Working Dogs to the Chagas Disease Parasite, Trypanosoma cruzi
por: Meyers, Alyssa C., et al.
Publicado: (2020)

Evaluation of the Chagas VirClia(®) and Chagas TESA VirClia(®) for the Diagnosis of Trypanosoma cruzi Infection
por: García-Bermejo, Isabel, et al.
Publicado: (2022)

Trypanosoma cruzi loop-mediated isothermal amplification (Trypanosoma cruzi Loopamp) kit for detection of congenital, acute and Chagas disease reactivation
por: Besuschio, Susana A., et al.
Publicado: (2020)

Role of PPARs in Trypanosoma cruzi Infection: Implications for Chagas Disease Therapy
por: Hovsepian, Eugenia, et al.
Publicado: (2012)

Strain-specific genome evolution in Trypanosoma cruzi, the agent of Chagas disease
por: Wang, Wei, et al.
Publicado: (2021)

Trypanosoma cruzi genetic diversity: impact on transmission cycles and Chagas disease
por: Zingales, Bianca, et al.
Publicado: (2022)

Experimental Trypanosoma cruzi Infection and Chagas Disease—A Word of Caution
por: Talvani, André, et al.
Publicado: (2023)

Galectins in Chagas Disease: A Missing Link Between Trypanosoma cruzi Infection, Inflammation, and Tissue Damage
por: Poncini, Carolina V., et al.
Publicado: (2022)

Recombinant antibody against Trypanosoma cruzi from patients with chronic Chagas heart disease recognizes mammalian nervous system.
por: Niborski, Leticia L., et al.
Publicado: (2021)

Inhibitors of Trypanosoma cruzi Sir2 related protein 1 as potential drugs against Chagas disease
por: Gaspar, Luís, et al.
Publicado: (2018)

Trypanosoma cruzi in the Chicken Model: Chagas-Like Heart Disease in the Absence of Parasitism
por: Teixeira, Antonio R. L., et al.
Publicado: (2011)

Aspirin Treatment of Mice Infected with Trypanosoma cruzi and Implications for the Pathogenesis of Chagas Disease
por: Mukherjee, Shankar, et al.
Publicado: (2011)

Chagas Cardiomyopathy Manifestations and Trypanosoma cruzi Genotypes Circulating in Chronic Chagasic Patients
por: Ramírez, Juan David, et al.
Publicado: (2010)

Métodos Diagnósticos para Trypanosoma cruzi en la enfermedad de Chagas : /
por: López Jiménez, Carlos Felipe
Publicado: (2015)

Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity
por: Zingales, Bianca, et al.
Publicado: (2014)

Detection of Trypanosoma cruzi by PCR in adults with chronic Chagas disease treated with nifurtimox
por: Vergara, Camilo, et al.
Publicado: (2019)

Fatal acute Chagas disease by Trypanosoma cruzi DTU TcI, Ecuador
por: Calvopina, Manuel, et al.
Publicado: (2020)

Trypanosoma cruzi parasitemia in chronic Chagas disease: Insights from hierarchical modeling
por: Abad-Franch, Fernando
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_31uecaei3un89uq60vceqe190v